GSK
GlaxoSmithKline PLC ADR
GlaxoSmithKline PLC ADR 13F Holders
GSK Stock Ownership Activity
- # of activities:
- 5
- AVG reported price*:
- $53.65
- Current price*:
- -8.09%($49.32)
5 value investing gurus have made changes to the GlaxoSmithKline PLC ADR (GSK) position according to the gurus' 2021 Q4 SEC quarterly report(s). GSK has been bought (as a new position) by 1, completely sold out by 1 guru(s), the number of GSK shares has been increased by 3 super investor(s).
Which gurus or hedge funds bought GSK in 2021 Q4?
According to the 2021 Q4 SEC filing(s) GlaxoSmithKline PLC ADR (GSK) has been bought by 4 gurus / funds: Dodge & Cox Stock Fund (added shares +0.72%), Kahn Brothers Group (added shares +6.30%), Tweedy, Browne Co All Funds (US) (added shares +7.53%) and Sarah Ketterer - Causeway Capital Management (new buy).
To see more about who is investing in GlaxoSmithKline PLC ADR (GSK), please go to the GSK ownership page.
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* AVG reported price: weighted average based on position sizes. Larger holdings have proportionally more influence on the average. This doesn't represent the actual buy or sell price. It is the split-adjusted average price of the securities as of the last day of the reported period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.